'09 billion' presentation slideshows

Kansas Department of Health and Environment

364 views • 19 slides

Bleeding Disorders Treatment Market Is Expected To Reach 15.09 Billion USD by 2021

The report "Bleeding Disorders Treatment Market by Type Hemophilia A, Hemophilia B, vWD and others, by Drug Class - Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant and Others - Global Forecast to 2021", report provides a detailed overview of the major drivers, restraints, threats, opportunities, current market trends, and strategies impacting the bleeding disorders treatment market along with the estimates and forecasts of the revenue and market share analysis.

158 views • 7 slides

Bleeding Disorders Treatment Market

The global bleeding disorders treatment market is projected to reach USD 15.09 Billion by 2021 from USD 10.33 Billion in 2016, at a CAGR of 7.9% from 2016 to 2021. The global market is broadly classified into type, drug class, and region.

89 views • 7 slides

Increasing Number of Diagnosed Hemophilia Patients To Drive Bleeding Disorders Treatment Market

The global bleeding disorders treatment market is expected to reach USD 15.09 Billion by 2021 from USD 10.33 Billion in 2016 at a CAGR of 7.9% from 2016 to 2021. The major factors driving the market growth include the growing patient population base, R&D activities, and increasing focus on recombinant products by pharmaceutical companies. Emerging markets offer significant growth opportunities for the market. On the other hand, high treatment cost for bleeding disorder treatment products coupled with limited reimbursement is expected to hinder the growth of this market during the forecast period.

92 views • 7 slides